Trial NCT02797522

View at ClinicalTrials.gov 
Org. Study IDs: ARC5211001

Last trial update was posted on 2018-09-25

MeSH Interventions

Acetaminophen Entecavir Histamine Antagonists Histamine H1 Antagonists Tenofovir

MeSH Conditions

Hepatitis Hepatitis A Hepatitis B Hepatitis B, Chronic

Other Conditions


Stopping Reasons

Company decision to discontinue trial

Limitations And Caveats

The ARC-521 Injection development program was terminated early for regulatory and business reasons secondary to findings occurring in a non-clinical toxicology study. Program termination was not due to safety findings in humans.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID